1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders

2. Research & Forecasting
2.1. Research Methodology
2.1.1. Research Process
2.1.2. Research Framework
2.1.3. Research Reliability & Validity
2.1.4. Research Assumptions
2.2. Forecasting Methodology
2.3. Research Outcome
2.3.1. 360iResearch Competitive Strategic Window
2.3.1.1. Leverage Zone
2.3.1.2. Vantage Zone
2.3.1.3. Speculative Zone
2.3.1.4. Bottleneck Zone
2.3.2. 360iResearch FPNV Positioning Matrix
2.3.2.1. 360iResearch Quadrants
2.3.2.1.1. Forefront
2.3.2.1.2. Pathfinders
2.3.2.1.3. Niche
2.3.2.1.4. Vital
2.3.2.2. Business Strategy
2.3.2.2.1. Business Growth
2.3.2.2.2. Industry Coverage
2.3.2.2.3. Financial Viability
2.3.2.2.4. Channel Support
2.3.2.3. Product Satisfaction
2.3.2.3.1. Value for Money
2.3.2.3.2. Ease of Use
2.3.2.3.3. Product Features
2.3.2.3.4. Customer Support

3. Executive Summary
3.1. Outlook in the Liver Cancer Drugs Market
3.2. Opportunities in the Liver Cancer Drugs Market

4. Premium Insight
4.1. Market Connectivity
4.2. Market Dynamics
4.2.1. Drivers
4.2.2. Restraints
4.2.3. Opportunities
4.2.4. Challenges
4.3. Porter’s Five Forces Analysis
4.3.1. Threat of New Entrants
4.3.2. Threat of Substitutes
4.3.3. Bargaining Power of Customers
4.3.4. Bargaining Power of Suppliers
4.3.5. Industry Rivalry
4.4. Industry Trends
4.4.1. Pipeline Analysis

5. Global Liver Cancer Drugs Market, by Type
5.1. Overview
5.2. Market Sizing & Forecasting
5.3. Immuno Therapy
5.4. Targeted Therapy

6. Global Liver Cancer Drugs Market, by Geography
6.1. Overview
6.2. Market Sizing & Forecasting
6.3. Americas
6.3.1. Overview
6.3.2. Market Sizing & Forecasting
6.3.3. Argentina
6.3.4. Brazil
6.3.5. Canada
6.3.6. Mexico
6.3.7. United States
6.4. Asia-Pacific
6.4.1. Overview
6.4.2. Market Sizing & Forecasting
6.4.3. Australia
6.4.4. China
6.4.5. India
6.4.6. Japan
6.5. Europe, Middle East & Africa
6.5.1. Overview
6.5.2. Market Sizing & Forecasting
6.5.3. France
6.5.4. Germany
6.5.5. Italy
6.5.6. Spain
6.5.7. United Kingdom

7. Competitive Landscape
7.1. 360iResearch FPNV Positioning Matrix for Global Liver Cancer Drugs Market
7.2. Market Vendor Ranking Analysis for Global Liver Cancer Drugs Market
7.3. Competitive News Feed Analysis for Global Liver Cancer Drugs Market

8. Company Usability Profiles
8.1. Bayer AG
8.1.1. Overview
8.1.2. Strategy
8.1.3. SWOT
8.2. Bristol-Myers Squibb
8.2.1. Overview
8.2.2. Strategy
8.2.3. SWOT
8.3. Eisai Co., Ltd.
8.3.1. Overview
8.3.2. Strategy
8.3.3. SWOT
8.4. Exelixis, Inc.
8.4.1. Overview
8.4.2. Strategy
8.4.3. SWOT
8.5. Merck & Co., Inc.
8.5.1. Overview
8.5.2. Strategy
8.5.3. SWOT
8.6. Alnylam Pharmaceuticals, Inc.
8.7. Ono Pharmaceutical Co., Ltd.

9. Appendix
9.1. Discussion Guide
9.2. Top Reports
9.2.1. Global Computer Vision Market - Premium Insight, Competitive News Feed Analysis, Company Usability Profiles, Market Sizing & Forecasts to 2025
9.2.2. Global Payment Gateway Market - Premium Insight, Competitive News Feed Analysis, Company Usability Profiles, Market Sizing & Forecasts to 2025
9.2.3. Global B2B Travel Market - Premium Insight, Competitive News Feed Analysis, Company Usability Profiles, Market Sizing & Forecasts to 2025
9.2.4. Global Varicose Vein Treatment Devices Market - Premium Insight, Competitive News Feed Analysis, Company Usability Profiles, Market Sizing & Forecasts to 2025
9.2.5. Global Fitness App Market - Premium Insight, Competitive News Feed Analysis, Company Usability Profiles, Market Sizing & Forecasts to 2025
9.3. Author Details